Abstract |
The antimetabolite 5-Fluorouracil (5-FU) is used in the treatment of various forms of cancer and has a complex mode of action. Despite 6 decades in clinical application the contribution of 5-FdUTP and dUTP [(5-F)dUTP] and 5-FUTP misincorporation into DNA and RNA respectively, for 5-FU-induced toxicity is still under debate.This study investigates DNA replication defects induced by 5-FU treatment and how (5-F)dUTP accumulation contributes to this effect. We reveal that 5-FU treatment leads to extensive problems in DNA replication fork progression, causing accumulation of cells in S-phase, DNA damage and ultimately cell death. Interestingly, these effects can be reinforced by either depletion or inhibition of the deoxyuridine triphosphatase ( dUTPase, also known as DUT), highlighting the importance of (5-F)dUTP accumulation for cytotoxicity.With this study, we not only extend the current understanding of the mechanism of action of 5-FU, but also contribute to the characterization of dUTPase inhibitors. We demonstrate that pharmacological inhibition of dUTPase is a promising approach that may improve the efficacy of 5-FU treatment in the clinic.
|
Authors | Anna Hagenkort, Cynthia B J Paulin, Matthieu Desroses, Antonio Sarno, Elisée Wiita, Oliver Mortusewicz, Tobias Koolmeister, Olga Loseva, Ann-Sofie Jemth, Ingrid Almlöf, Evert Homan, Thomas Lundbäck, Anna-Lena Gustavsson, Martin Scobie, Thomas Helleday |
Journal | Oncotarget
(Oncotarget)
Vol. 8
Issue 14
Pg. 23713-23726
(Apr 04 2017)
ISSN: 1949-2553 [Electronic] United States |
PMID | 28423595
(Publication Type: Journal Article)
|
Chemical References |
- Antimetabolites, Antineoplastic
- Enzyme Inhibitors
- Pyrophosphatases
- dUTP pyrophosphatase
- Fluorouracil
|
Topics |
- Antimetabolites, Antineoplastic
(administration & dosage, pharmacology)
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology)
- Cell Line, Tumor
- DNA Replication
(drug effects)
- Drug Synergism
- Enzyme Inhibitors
(administration & dosage, pharmacology)
- Fluorouracil
(administration & dosage, pharmacology)
- HeLa Cells
- Humans
- Neoplasms
(drug therapy, enzymology, genetics)
- Pyrophosphatases
(antagonists & inhibitors)
|